Tapping Specialty Market Potential Tops SPT Week in Review

5. ODAC Recommends Approval for Herceptin Biosimilar

Trastuzumab is indicated as an adjuvant therapy for HER2-positive breast cancer, along with metastatic breast and gastric cancers. Read more…

4. Cancer Mortality High in Rural America

Rural areas have a higher rate of death for lung, colorectal, prostate, and cervical cancers. Read more…

3. Patients Say Biosimilars, Biologics Should Require Same Type, Level of Testing

New report provides insight into patient awareness and attitudes towards biosimilars. Read more…

2. Specialty Drugs Provide Financial Challenges for Employers

Integrating medical and pharmacy benefits may better inform employer management of specialty drugs. Read more…

1. Is it Time to Take Another Look at Retail at Specialty Pharmacy?

The concept of specialty at retail has the potential to unlock vast financial, contracted volume, and patient continuum of care opportunities attached to pharmaceutical products currently dispensed in specialty pharmacies. Read more…